Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining.
Camille MorivalRichard WesterlynckGuillaume BouzilléMarc CuggiaPascal A Le CorrePublished in: European journal of clinical pharmacology (2017)
Different drug-drug interaction profiles were observed between statins with a higher prevalence of CYP3A4-based interactions for lipophilic statins. Analyzing the three most frequent DDIs, the more significant DDIs (level 1: contraindication) were reported for transporter-based DDI involving OATP1B1 influx transporter. These points are of concern to improve prescriptions of statins.